 All right, so we're going to open it up for 10 minutes of questions. So Tom you're welcome to come back and Ray And simmer so I think we'll have some really interesting questions because a lot was was presented and really interesting experience all of us have had so We'll we'll go to about 10 10 and take a quick five minute break Come on up Tom Any questions or comments? I think the Vinod, I think alluded to the fact that there is a faster way of accessing data using the MD clone Platform before you get IRB approval and I think that Pathways through collaborating with a VA researcher for example and then having them reach out to Amanda Lee now so that You can at least get Access to some form of synthetic data platform that does not have any Identifiable information while you're preparing for IRB. So I know that It can be daunting to look at the at the calendar that starts at 2022 and your analysis is 2024 for a four-year PhD course so It's daunting, but it's not impossible I think in data science we call it an outlier experience hopefully Well, I don't know if it's an outlier I can't see the questions from the audience, but I'll excuse me from the virtual audience go ahead here taking your learnings and and actually changing the course of care diagnostic approach to Finding these these, you know rare, but maybe not so rare prevalent disease profiles I Think that's a that's an excellent question because I mean that's the point of this is to all to improve care and For a rare disease like cardiac amyloidosis I think that accurate phenotyping and being able to pull real cases from the data is incredibly important And I think that's something that you know, maybe we should publish at some point doctor They've you've mentioned this before but having a systematic way of pulling cases and then validating that I think that's that's important and Yeah, I think that you know in practice and we've The teams already developed a screening of dashboard based on some of this this data That is going into practice now To help target screening so we can identify these patients earlier. I Don't know if you want to comment on that dr. Dave. I Had a question for Dr. McReyno and as and a similar question Force dr. Simmer and for Tom where? so my question is first Dr. McReyno, so What help do you need so that there are 50 times the number of researchers? That are interacting with the data in the empty clone Adams platform because as you said that it's a gold mine what help do you need for that to happen and I'll state the question and then I'd like you to answer dr. Ray Similar question to Simmer and to Tom, you know, you've got many colleagues out there In your space. What help do you need now to get the message across to them so they can also get the benefits of That you've reaped for your professional development So I'm I'm talk. I'm gonna be talking in general. There's a lot of clinician scientists scientists and trainees who have a lot of research questions and of course it's like they know that the VA data is a repository of a large data set and In terms of help, I think how to get from an idea or a question to getting actual data that you can analyze A lot of it is Skill sets in biostatistics as well as data management And so if you're going to the Vinci platform, it's very sequel query based lots of Data even though it's curated Needs a lot of processing to make sure that it's not garbage in garbage out So there's in the old days when Sandesh and I did Vinci 90% of the time is just data I Guess cleaning up the data at least that's my experience so Some if you are to have a data management team, you need to have Personnel who can do those? basic stuff, you know Access the data clean up the data Get the data ready for analysis and then have a biostat person to help you with the analysis With then with a platform such as Arches MD clone Adams. It's a little bit a lot of these things are Are facilitated? The only the only concern I have is that We have Decades of experience and how Vinci presents the CDW data and how How to to clean it up? We don't have that knowledge about what MD clone is doing to the VA data and CDW data Whereas we it's like a black box to us and so You really need to validate whatever you come up with this easier platform with the actual You know with with a non with a with a CDW raw data Just to make sure that the this this process of cleaning up the data sets for errors or whatever Are as rigorous as the old traditional way? Is that makes sense? I would say the hope that I would need Would be particular to the steps or the context to Make the connection of the potential collaborators and Accessing the the VA system I'm not quite sure what that looks like from my perspective Because there are a couple researchers within my IS department who would be Potentially interested in this in this type of work actually, there's a he's a IS professor within Within IS PhD, but also a medical doctor from his home at his home country and so he is quite familiar with with health care in the medical in the medical scene, but And we are interested working together, but I'm not quite sure how to Make that connection considering Like the permissions and the access Requests that would need to to be given so having a comprehensive understanding of what it would take to like as me Now being a VA researcher to hope someone else would be be beneficial You know, I would I would echo that I think having contacts in The field of your interest would be important You know if my fellow residents and there's I think 32 of them in my year, so there's 90 of us I think total if they knew that there was a researcher in Arizona who was interested in the similar field with IRB approval already perhaps Who can help facilitate them to get the data and get access to MD clone and and then start Asking questions. I think that would be a Tremendous way to get more users. I think it would facilitate things So I'm not sure if that's possible if we can get you know a list of people who are using the platform who have experience with accessing VA data in in their particular field and May have the best interest in kind of collaborating on a research question It also mentioned, you know that That we do need to enhance training for clinical research, right? So both for clinicians as well as scientists who are engaged in clinical research And I think that we do have some strengths in the state But they're sort of unequally distributed and they're not always accessible to clinicians, right? So do we have a night program for clinical research training or something like that? I don't think it exists in Phoenix right now I could be wrong, but I don't think it exists. So I think it's also data access as well as skills development So why don't we continue this during the three-minute break and I'll see you back in three